Wednesday, 20 January 2010
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2010
(311)
-
▼
January
(23)
- Recipharm will add aseptic filling and lyophilsati...
- Albemarle fine chemicals sales decline
- Sales in Johnson Matthey's Fine Chemicals Division...
- Merck builds pharma salts plant
- Lonza has been awarded the 2010 Sandmeyer Prize fo...
- Wacker Chemie has expanded its bacterial secretion...
- AMRI has received SafeBridge Potent Compound Safet...
- German grant for downstream processing research
- Jubilant Organosys plans to raise funds
- Angel Biotechnology signed eight contracts worth £...
- Dishman to build four API plants
- Baring Private Equity Partners is in discussions t...
- Rentschler Biotechnologie will develop a manufactu...
- Recipharm has posted the details of its offer for ...
- Lonza closes API plant
- Dishman plans to raise $16.4m by issuing non-conve...
- Angel Biotechnology has signed a frame agreement a...
- Dishman seeks 20% growth in CRAMS
- 26 drugs approved in 2009
- On 1 January Evonik took over the Teppecanoe facil...
- Marksans to sell API manufacturing plants to conce...
- Ranbaxy withdraws from Chinese manufacturing jv
- Codexis refiles for $100m IPO
-
▼
January
(23)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment